HOPE — Execution
Supports United Kingdom human organ engineering collaborations focused on translational tissue platforms.
HOPE — Human Organs, Physiology, and Engineering — is a $50 million Wellcome Leap program focused on engineering human tissues and organs for two primary applications: creating a multiorgan platform that replicates human immune responses for drug testing, and advancing bioengineered kidney technology to improve survival outcomes for patients with end-stage renal disease. The program is led by Prog…
Human tissue, organoid, and bioengineered organ development for drug testing and end-stage renal disease treatment, through academic, foundation, and private-sector collaboration.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Find grantsGrants for Small Business Startup: Eligibility Checklist
Check whether your deeptech company is eligible for grants for small business startup funding, including SBIR/STTR, EIC Accelerator, and Innovate UK support.
DocumentsGrant Checklist: Application Documents, Forms, and Examples
Use this grant checklist to see the documents, forms, narratives, budgets, evidence, and compliance attachments a grant application may require.
More from Wellcome Leap
All grants from this funder →1kD — Execution
Wellcome Leap · United States
Funds United Kingdom infant brain development research programs focused on translational collaboration.
CARE — Execution
Wellcome Leap · United States
Supports United Kingdom efforts to understand endocrine factors in cognitive aging and dementia risk.
Delta Tissue — Execution
Wellcome Leap · United States
Funds United Kingdom tissue profiling research for improved diagnostics and disease state understanding.
Dynamic Resilience — Execution
Wellcome Leap · United States
Funds healthspan-oriented research in the United Kingdom toward resilient aging and wellness strategies.
Focused Antibiotics
Wellcome Leap · United States
Funds United Kingdom and global teams redesigning antibiotic strategies while preserving gut microbiome health.
FORM
Wellcome Leap · United States
Funds United Kingdom maternal and infant microbiome research to improve long-term health outcomes.
Similar grants
Browse the directory →
ARPA-H Mission Office ISOs
🇺🇸ARPA-H · United States
Supports United States mission teams with boundary-pushing health initiatives beyond existing programme limits.
ARPA-H SBIR/STTR
🇺🇸ARPA-H · United States
Funds United States small businesses bridging health and neuroscience technologies from feasibility into advanced development.
ARPA-H Initiatives & Sprints
🇺🇸ARPA-H · United States
Runs fast-turnaround health technology opportunities in United States for high-potential exploratory science and engineering.
ARPA-H Program ISOs (topic-specific)
🇺🇸ARPA-H · United States
Funds United States health initiatives through topic-focused pathways across multiple mission areas and agencies.
DARPA BTO Office-wide BAA
🇺🇸DARPA · United States
Funds United States convergence work in biology, neurotechnology, and synthetic biology for strategic defense purposes.
Co-Innovation
🇫🇮Business Finland · Finland
Funds Finnish companies running joint R&D projects with public research organisations through Business Finland's Co-Innovation scheme.